FR2773157B1 - Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide - Google Patents

Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide

Info

Publication number
FR2773157B1
FR2773157B1 FR9716673A FR9716673A FR2773157B1 FR 2773157 B1 FR2773157 B1 FR 2773157B1 FR 9716673 A FR9716673 A FR 9716673A FR 9716673 A FR9716673 A FR 9716673A FR 2773157 B1 FR2773157 B1 FR 2773157B1
Authority
FR
France
Prior art keywords
serum
patients
peptide epitopes
epitopes recognized
autoantibodies present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9716673A
Other languages
English (en)
French (fr)
Other versions
FR2773157A1 (fr
Inventor
Guy Bruno Rene Serre
Neuhauser Elisabeth Girbal
Christian Vincent
Michel Simon
Mireille Sebbag
Pascal Dalbon
Reynaud Colette Jolivet
Michel Arnaud
Michel Jolivet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Priority to FR9716673A priority Critical patent/FR2773157B1/fr
Priority to PCT/FR1998/002899 priority patent/WO1999035167A1/fr
Priority to CA002316269A priority patent/CA2316269A1/fr
Priority to EP98964536A priority patent/EP1042366A1/de
Priority to AU19717/99A priority patent/AU1971799A/en
Publication of FR2773157A1 publication Critical patent/FR2773157A1/fr
Application granted granted Critical
Publication of FR2773157B1 publication Critical patent/FR2773157B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
FR9716673A 1997-12-30 1997-12-30 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide Expired - Fee Related FR2773157B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9716673A FR2773157B1 (fr) 1997-12-30 1997-12-30 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
PCT/FR1998/002899 WO1999035167A1 (fr) 1997-12-30 1998-12-29 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
CA002316269A CA2316269A1 (fr) 1997-12-30 1998-12-29 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
EP98964536A EP1042366A1 (de) 1997-12-30 1998-12-29 Peptidische epitope, von gegen filaggrin gerichteten, im serum der an rheumatoiden polyarthritis leidenden patienten anwesenden autoantikörpern anerkannt
AU19717/99A AU1971799A (en) 1997-12-30 1998-12-29 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9716673A FR2773157B1 (fr) 1997-12-30 1997-12-30 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide

Publications (2)

Publication Number Publication Date
FR2773157A1 FR2773157A1 (fr) 1999-07-02
FR2773157B1 true FR2773157B1 (fr) 2001-10-05

Family

ID=9515272

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9716673A Expired - Fee Related FR2773157B1 (fr) 1997-12-30 1997-12-30 Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide

Country Status (5)

Country Link
EP (1) EP1042366A1 (de)
AU (1) AU1971799A (de)
CA (1) CA2316269A1 (de)
FR (1) FR2773157B1 (de)
WO (1) WO1999035167A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773078B1 (fr) * 1997-12-30 2000-05-26 Univ Toulouse Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
AU2012301A (en) * 1999-12-21 2001-07-03 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
FR2826124B1 (fr) * 2001-06-13 2004-01-02 Bio Merieux Procede de detection d'auto-anticorps specifiques de la polyarthrite rhumatoide
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
PT1882946E (pt) 2003-12-23 2010-04-21 Roche Diagnostics Gmbh Método para avaliar artrite reumatóide através da medição de anti-ccp e interleucina 6
ES2314621T3 (es) 2004-02-27 2009-03-16 F. Hoffmann-La Roche Ag Procedimiento de evaluacion de la artritis reumotoidea, mediante la medicion de anti-ccp y amiloide a serico.
ES2545688T3 (es) 2006-09-29 2015-09-15 F. Hoffmann-La Roche Ag Método de evaluación del riesgo de progresión de enfermedad de pacientes con artritis reumatoide
EP2336769A1 (de) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Assay zur Unterscheidung zwischen rheumatischen und nicht rheumatischen Leiden
EP3056903A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-Casp8
EP3056904A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-MCM3
JP2018506720A (ja) 2015-02-13 2018-03-08 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 抗ｃｃｐおよび抗ｐｉｋ３ｃｄを測定することによる関節リウマの査定方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752842B1 (fr) * 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide

Also Published As

Publication number Publication date
AU1971799A (en) 1999-07-26
CA2316269A1 (fr) 1999-07-15
WO1999035167A1 (fr) 1999-07-15
FR2773157A1 (fr) 1999-07-02
EP1042366A1 (de) 2000-10-11

Similar Documents

Publication Publication Date Title
NO991449D0 (no) Antistoff mot human parathormon-relaterte peptider
DE69625597D1 (de) I/o-prozessor architektur mit integrierter pci-pci brücke
IS5375A (is) KAY-nýstárlegt ónæmisprótín
NO980915L (no) Rekombinante anti-CD4-antistoff egnet for human terapi
DK91192D0 (da) Protein
FI965030A0 (fi) Hiivassa ekspressoituneet N-terminaalisesti pidennetyt proteiinit
DE69319662D1 (de) Monoklonale Antikörper gegen GP130-Protein
DE69625233D1 (de) Einrichtung vom flipchiptyp
ATE348151T1 (de) Protein mit phospholipaseaktivität
NO960956L (no) Rekombinante IL4-antistoffer anvendelige ved behandling av IL4-betingede forstyrrelser
FR2773157B1 (fr) Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
DE69625321D1 (de) Leistungswandler vom brückentyp
FI952069A (fi) Vähäallergeeniset proteiinit
DE58900884D1 (de) Oeffnungshilfe fuer ampullen.
FI972030A (fi) Puhdistettuja papillomavirusproteiineja
FR2631239B1 (fr) Anticorps monoclonal humain et hybridome le produisant
IT1231727B (it) Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
ATA74890A (de) Abscheider fuer leichtfluessigkeiten
ITTO960496A0 (it) Modificatione di farmaci polipeptidici per accrescere il flusso per e-lettrotrasporto.
AU5435990A (en) Monoclonal antibodies to human glutathione s transferase pi
FI964606A (fi) Tumaproteiinien kanssa vuorovaikutuksessa oleva faktori
DK354989D0 (da) Modificerede proteiner
IL129273A (en) Monoclonal antibody to placental protein 13 and immunoassay and kit using said antibody
DE69420044D1 (de) Blutregulierende peptide

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060831